OraSure Technologies Invites You to Join Its Discussion Regarding Recent Publication on the Company's UPT Technology, Monday, March 12, 2001, at 11:00 a.m. ET
BETHLEHEM, Pa.--(BUSINESS WIRE)----March 7, 2001--OraSure Technologies Inc. (NasdaqNM:OSUR) will hold a conference call to discuss the recently published research report about OraSure Technologies' UPT(TM) technology called, "Up-converting phosphor reporters for nucleic acid microarrays." The article was published in Nature Biotechnology, the premier magazine for the biotechnology industry. Due to the important findings of this article and the complex nature of the subject matter, OraSure Technologies will be conducting a simultaneous Webcast and PowerPoint presentation to further explain this technology to the business and financial community.
This call is being webcast on March 12, 2001, at 11:00 a.m. Eastern by CCBN. To listen to the webcast and to view a related PowerPoint presentation, go to OraSure's Web site at www.orasure.com. On the call will be Robert D. Thompson, chief executive officer, and R. Sam Niedbala, chief science officer and executive vice president. To participate in the teleconference, five minutes prior to 11:00 a.m. Eastern Time, on Monday, March 12, please dial 800/406-5345. Please use the conference code 413577. Callers will be placed in a listen only mode.
A copy of the press release describing this article will be available before the market opens on Monday, March 12, 2001. The webcast and PowerPoint presentation will also be archived on the OraSure Web site for 30 days following the call.
Please contact Michelle Sells, investor relations manager for OraSure Technologies, at 503/641-6115 with any questions.
The webcast will also be distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.companyboardroom.com or by visiting any of the investor sites in CCBN's Individual Investor Network such as America Online's Personal Finance Channel, Fidelity Investments(R) (Fidelity.com) and others. Institutional investors can access the call via CCBN's password protected event management site, StreetEvents (www.streetevents.com). StreetEvents allows institutional investors to identify, organize, and track the hundreds of conference calls that occur each day during earnings season, to download events of interest to their Outlook calendar, and to RSVP to events online.
About OraSure
OraSure Technologies Inc. develops, manufactures and markets medical devices and diagnostic products for use by public- and private-sector clients, clinical laboratories, physicians' offices and workplace testing. OraSure Technologies is the leading supplier of oral fluid collection devices and assays to the life insurance industry and public health markets for the detection of antibodies to HIV. In addition, the company supplies oral fluid testing solutions for drugs-of-abuse testing. For more information on the company please visit www.orasure.com.
CONTACT:
OraSure Technologies Inc.
Michelle Sells, 503/641-6115 ext. 6233
or
Rich Hooper, 610/882-1820 ext. 3042
investorinfo@orasure.com
